glp 1 medication and ms Episode 444: A GLP-1 Drug for MS? with Dr. Ellen Mowry glp-1 drugs and multiple sclerosis

All other data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary Materials

Market Some overseas companies will likely begin marketing semaglutide to U.S

Foundayo: oral GLP-1 for weight loss Foundayo (generic name: orforglipron) is the second GLP-1 pill approved for weight loss, following Novo Nordisks Wegovy pill (not yet approved in Singapore) late last year

Opioid Use Disorder Outcomes In another study by Wang, Volkow, and colleagues, which included roughly 33,000 individuals with Type 2 diabetes and opioid use disorder, semaglutide was associated with a 42-68% lower risk of opioid overdoses compared to other diabetes medications during the 1-year follow-up period (Wang et al., 2024b)